UBS Group’s Clover Leaf Capital Corp. Rights CLOER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-21
Closed -$3 10304
2024
Q1
$3 Buy
+21
New +$3 ﹤0.01% 9174
2023
Q3
Sell
-102
Closed -$12 10138
2023
Q2
$12 Buy
+102
New +$12 ﹤0.01% 8723
2023
Q1
Sell
-948
Closed -$76 10721
2022
Q4
$76 Buy
948
+136
+17% +$10 ﹤0.01% 10435
2022
Q3
$0 Buy
812
+98
+14% +$6 ﹤0.01% 11146
2022
Q2
$0 Sell
714
-26
-4% -$4 ﹤0.01% 11158
2022
Q1
$0 Buy
+740
New +$252 ﹤0.01% 11098

Other funds holding CLOER

UBS Group's CLOER Position: Q2 2024 in Review

UBS Group sold out of Clover Leaf Capital Corp. Rights (CLOER) in Q2 2024, closing a stake of 21 shares — an estimated $3 sold.

UBS Group first reported a position in CLOER in Q1 2022 and held it in 6 quarters. The position peaked at $76 in Q4 2022. 25 funds tracked by Wall St. Rank hold CLOER as of Q2 2024.

  • UBS Group reported no remaining Clover Leaf Capital Corp. Rights position as of Q2 2024 after selling out during the quarter.
  • UBS Group sold 21 Clover Leaf Capital Corp. Rights shares in Q2 2024, an estimated $3.
  • UBS Group first reported a position in Clover Leaf Capital Corp. Rights in Q1 2022 and held it in 6 quarters.
  • UBS Group's Clover Leaf Capital Corp. Rights position peaked at $76 in Q4 2022.
  • 25 funds tracked by Wall St. Rank held Clover Leaf Capital Corp. Rights as of Q2 2024.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.